Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129228 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography of the Saphenous Vein Graft
A NA study of Coronary Bypass Graft Stenosis, sponsored by St. Francis Hospital, New York.
- Recruiting
- Registry status
- NA
- Development phase
- 760
- Enrollment target
- 1
- Study location
NCT05129228: Recruiting NA study of Coronary Bypass Graft Stenosis, sponsored by St. Francis Hospital, New York.
NCT05129228 is a NA study of Coronary Bypass Graft Stenosis that is actively recruiting participants, run by St. Francis Hospital, New York. The registered enrollment target is 760 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05129228, a NA study of Coronary Bypass Graft Stenosis, is actively recruiting participants, sponsored by St. Francis Hospital, New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 760 participants
- Enrollment target
- 1
- Study location
Study Summary
OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).
Conditions Studied
Interventions
- DEVICE OCT-guided saphenous vein CABG
Study Locations (1)
New York
- St Francis Hospital - Roslyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2026-04-04 |
| Phase | NA |
What NCT05129228 shows while recruiting
NCT05129228 is an interventional study that assigns participants to a tested intervention. The registered 760 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Coronary Bypass Graft Stenosis appearing as the primary indexed condition, and to 1 intervention - of which OCT-guided saphenous vein CABG is the first listed.
NCT05129228 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05129228 about?
NCT05129228 is a clinical study titled "Optical Coherence Tomography of the Saphenous Vein Graft". OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).
What is the current status of trial NCT05129228?
This trial is currently recruiting. It is a NA study. The enrollment target is 760 participants. The study started on 2022-04-04. Estimated completion is 2026-04-04.
What conditions does trial NCT05129228 study?
This clinical trial studies the following conditions: Coronary Bypass Graft Stenosis.
What interventions are being tested in trial NCT05129228?
The interventions under investigation include: OCT-guided saphenous vein CABG (DEVICE).
Who is sponsoring clinical trial NCT05129228?
This trial is sponsored by St. Francis Hospital, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05129228 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Bypass Graft Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05129228's enrollment target sits among peer trials
760 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
- NCT06295367 · 760 participants · NA
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI